Axicabtagene ciloleucel,Cyclophosphamide,Fludarabine
gilead
['axi-cel', 'lymphoma']
#asco23 news: axi-cel significantly improves survival in patients with early relapsed/refractory large b-cell lymphoma || for more of the top and trending #asco23 news, visit: #oncology #hematology #onctwitter #medtwitter #carttherapy #asco2023 
Your source for the latest in oncology news.